Deep Dive: Measles in Pregnancy and Congenital Cases — Background, What Changed, Viewpoints, and What to Watch

Background

Measles during pregnancy is uncommon in the modern era precisely because high vaccination rates had made the disease rare. When it occurs, it raises risks of pneumonia, maternal death, miscarriage, stillbirth, and premature birth. Congenital measles—infection acquired around the time of birth—had not been documented in the United States for decades.

In Pennsylvania’s 2026 outbreak, state officials reported at least 66–77 pregnant women with measles and at least six newborns born with the infection. At least two infant deaths in the state have been linked to the outbreak. Most U.S. clinicians have little recent experience managing these cases.

What changed

On 19 October 2026 the Pennsylvania Department of Health issued a health alert noting congenital measles for the first time in decades. CDC scientists prepared an urgent Health Alert Network notice to give clinicians guidance. According to reporting by The Washington Post (30 October 2026), that rapid alert was not approved. Scientists then began preparing material for the slower MMWR journal process.

Dr. Tom Frieden noted on 2 November that Pennsylvania alone has seen 77 pregnant cases and at least six congenital infections, and that a national figure could exceed 200 if rates hold. There is no national tracking system for congenital measles.

Competing viewpoints

Public-health advocates argue that blocking or delaying the clinician alert leaves providers without timely guidance at a moment when cases are rising and experience is low. Others note that states are already issuing their own advisories and that clinicians can access existing literature on measles in pregnancy. Debate also continues over whether the outbreak’s adult-heavy pattern and congenital cases should change recommendations around preconception vaccination or earlier infant dosing in high-risk areas.

What to watch next

Parents: if you are pregnant or planning pregnancy and unvaccinated, or live in an outbreak area, discuss timing of MMR and post-exposure options with your clinician. Infants under 12 months (or 6 months in some outbreak settings) rely on maternal antibodies and community protection.

Sources: Washington Post (Lena H. Sun), Pennsylvania Department of Health alerts, CDC data, statements from former CDC Director Tom Frieden.